The impact of vaginal progesterone and vitamin D3 on the treatment of unexplained recurrent abortio
Not Applicable
- Conditions
- Recurrent abortion.spontaneous abortion
- Registration Number
- IRCT2013100114853N1
- Lead Sponsor
- Vice Chancellor for research, Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
Incidence of 3 or more consecutive recurrent abortions or 2 or more non consecutive abortions; Age less than 35 years and above 18 years; The absence of any known causes of abortion; Pregnancies from one single husband in previous and current abortions
Exclusion criteria: Uterine anomalies; The history of allergy on the consumption of progesterone and multivitamins containing vitamin D3; initial abnormal tests of thyroid abnormalities, prolactin, antiphospholipid antibody syndrome and thrombophilia
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Continuation of pregnancy beyond 20 weeks of pregnancy in women with recurrent abortion. Timepoint: 20 weeks after the first day of last menstural period. Method of measurement: clinical, laboratory and sonographic findings.
- Secondary Outcome Measures
Name Time Method Continuation of pregnancy. Timepoint: after pregnancy termination. Method of measurement: after pregnancy termination.